nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer
|
Bellone, Matteo |
|
2017 |
36 |
C |
p. 17-24 8 p. |
artikel |
2 |
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells
|
Cappuzzello, Elisa |
|
2017 |
36 |
C |
p. 99-105 7 p. |
artikel |
3 |
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
|
Sistigu, Antonella |
|
2017 |
36 |
C |
p. 67-77 11 p. |
artikel |
4 |
Editorial Board and Publication information
|
|
|
2017 |
36 |
C |
p. IFC- 1 p. |
artikel |
5 |
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)
|
Russo, Vincenzo |
|
2017 |
36 |
C |
p. 1-3 3 p. |
artikel |
6 |
Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy
|
Consonni, Michela |
|
2017 |
36 |
C |
p. 117-123 7 p. |
artikel |
7 |
Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences
|
CalabrĂ², Luana |
|
2017 |
36 |
C |
p. 25-31 7 p. |
artikel |
8 |
Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors
|
Seliger, Barbara |
|
2017 |
36 |
C |
p. 49-56 8 p. |
artikel |
9 |
Immunotherapy targeting immune check-point(s) in brain metastases
|
Di Giacomo, Anna Maria |
|
2017 |
36 |
C |
p. 33-38 6 p. |
artikel |
10 |
Improving homing in T cell therapy
|
Vignali, Debora |
|
2017 |
36 |
C |
p. 107-116 10 p. |
artikel |
11 |
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma
|
Fattore, Luigi |
|
2017 |
36 |
C |
p. 39-48 10 p. |
artikel |
12 |
New vaccination strategies in liver cancer
|
Buonaguro, Luigi |
|
2017 |
36 |
C |
p. 125-129 5 p. |
artikel |
13 |
Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors
|
Dammeijer, Floris |
|
2017 |
36 |
C |
p. 5-15 11 p. |
artikel |
14 |
Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors
|
Mondino, Anna |
|
2017 |
36 |
C |
p. 57-65 9 p. |
artikel |
15 |
The added value of type I interferons to cytotoxic treatments of cancer
|
Bracci, Laura |
|
2017 |
36 |
C |
p. 89-97 9 p. |
artikel |
16 |
Tumor-derived factors affecting immune cells
|
Russo, Vincenzo |
|
2017 |
36 |
C |
p. 79-87 9 p. |
artikel |